Business Context and Reporting Period
This Form 8-K filing by LeMaitre Vascular, Inc. (LMAT) reports on events occurring on November 30, 2021. The company is a Delaware corporation with principal executive offices in Burlington, Massachusetts.
Key Financial Metrics and Debt
- Debt Termination: The Company terminated its Credit Agreement dated June 22, 2020, with KeyBank National Association and Truist Bank.
- Facility Details: The agreement included a $40,000,000 senior secured term loan (repaid in full in Q3 2021) and a $25,000,000 senior secured revolving credit facility (no borrowings outstanding at termination).
- Liquidity Impact: The Security Agreement securing the debt was terminated simultaneously. No early termination penalties were incurred.
Material Changes and Unusual Items
- Non-Cash Charge: The Company incurred a one-time, non-cash charge of approximately $0.5 million related to the write-off of unamortized deferred financing costs.
- Income Impact: This charge will reduce Q4 2021 and full-year 2021 net income and earnings per share.
- Future Savings: Beginning in Q1 2022, the Company will save approximately $50,000 in quarterly cash and non-cash expenses associated with the terminated facilities.
Guidance and Management Commentary
The $0.5 million non-cash charge was not included in the Company's Q4 2021 or full-year 2021 guidance released on October 28, 2021. Management notes that the termination of the facilities eliminates future associated expenses.
Investor Verification Checklist
- Verify the exact impact of the $0.5 million non-cash charge on Q4 2021 earnings per share in the upcoming quarterly report.
- Confirm the absence of any remaining debt obligations or covenants following the termination of the Credit Agreement.
- Review the Q1 2022 financials to confirm the realization of the projected $50,000 quarterly expense savings.